Literature DB >> 4119013

[Diagnosis and conservative treatment of the prostatic adenoma].

W Brosig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4119013     DOI： 10.1007/bf01282668

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN： 0023-8236


× No keyword cloud information.
  5 in total

1.  TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.

Authors:  J GELLER; R BORA; T ROBERTS; H NEWMAN; A LIN; R SILVA
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

2.  [Gestagens--an effective conservative treatment of the so-called prostatic hypertrophy?].

Authors:  H Reichelt
Journal:  Wien Med Wochenschr       Date:  1970-11-07

3.  [Treatment of prostatic hypertrophy with depostat].

Authors:  M Nuri; K Hochberg
Journal:  Munch Med Wochenschr       Date:  1970-05-29

4.  [Treatment of hypertrophy of the prostate with gestagens].

Authors:  W Vahlensieck; S Gödde
Journal:  Munch Med Wochenschr       Date:  1968-06-28

5.  [Animal experimental studies using 19-nor-17 alpha-hydroxyprogesterone caproate (Gestenoroncapronat) with respect to a possible therapeutic application in prostatic adenoma].

Authors:  J D Hahn; F Neumann; R Berswordt-Wallrabe
Journal:  Urologe       Date:  1968 Jul-Aug       Impact factor: 0.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.